Literature DB >> 27926775

Cardiomyopathy in Muscular Dystrophy: When to Treat?

Elizabeth M McNally.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 27926775      PMCID： PMC5510024          DOI： 10.1001/jamacardio.2016.4910

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


× No keyword cloud information.
  4 in total

1.  Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy.

Authors:  Elizabeth M McNally; Jonathan R Kaltman; D Woodrow Benson; Charles E Canter; Linda H Cripe; Dongsheng Duan; Jonathan D Finder; William J Groh; Eric P Hoffman; Daniel P Judge; Naomi Kertesz; Kathi Kinnett; Roxanne Kirsch; Joseph M Metzger; Gail D Pearson; Jill A Rafael-Fortney; Subha V Raman; Christopher F Spurney; Shari L Targum; Kathryn R Wagner; Larry W Markham
Journal:  Circulation       Date:  2015-05-05       Impact factor: 29.690

2.  Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy: A Randomized Clinical Trial.

Authors:  Marly Conceição Silva; Tiago Augusto Magalhães; Zilda Maria Alves Meira; Carlos Henrique Reis Esselin Rassi; Amanda Cristina de Souza Andrade; Paulo Sampaio Gutierrez; Clerio Francisco Azevedo; Juliana Gurgel-Giannetti; Mariz Vainzof; Mayana Zatz; Roberto Kalil-Filho; Carlos Eduardo Rochitte
Journal:  JAMA Cardiol       Date:  2017-02-01       Impact factor: 14.676

3.  Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy.

Authors:  Denis Duboc; Christophe Meune; Guy Lerebours; Jean-Yves Devaux; Guy Vaksmann; Henri-Marc Bécane
Journal:  J Am Coll Cardiol       Date:  2005-03-15       Impact factor: 24.094

4.  Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial.

Authors:  Subha V Raman; Kan N Hor; Wojciech Mazur; Nancy J Halnon; John T Kissel; Xin He; Tam Tran; Suzanne Smart; Beth McCarthy; Michael D Taylor; John L Jefferies; Jill A Rafael-Fortney; Jeovanna Lowe; Sharon L Roble; Linda H Cripe
Journal:  Lancet Neurol       Date:  2014-12-30       Impact factor: 44.182
  4 in total
  3 in total

1.  In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice.

Authors:  Mona El Refaey; Li Xu; Yandi Gao; Benjamin D Canan; T M Ayodele Adesanya; Sarah C Warner; Keiko Akagi; David E Symer; Peter J Mohler; Jianjie Ma; Paul M L Janssen; Renzhi Han
Journal:  Circ Res       Date:  2017-08-08       Impact factor: 17.367

Review 2.  Advances in Stem Cell Modeling of Dystrophin-Associated Disease: Implications for the Wider World of Dilated Cardiomyopathy.

Authors:  Josè Manuel Pioner; Alessandra Fornaro; Raffaele Coppini; Nicole Ceschia; Leonardo Sacconi; Maria Alice Donati; Silvia Favilli; Corrado Poggesi; Iacopo Olivotto; Cecilia Ferrantini
Journal:  Front Physiol       Date:  2020-05-12       Impact factor: 4.566

Review 3.  Drug development progress in duchenne muscular dystrophy.

Authors:  Jiexin Deng; Junshi Zhang; Keli Shi; Zhigang Liu
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.